    ﻿{"id":590938,"date":"2025-06-09T10:03:59","date_gmt":"2025-06-09T02:03:59","guid":{"rendered":"https:\/\/beta3.law.asia\/?p=590938"},"modified":"2025-08-25T10:54:55","modified_gmt":"2025-08-25T02:54:55","slug":"pharma-ipo-income-indicators-risks-anti-corruption","status":"publish","type":"post","link":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/","title":{"rendered":"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669"},"content":{"rendered":"<p style=\"text-align: justify;\">\u672c\u6587\u5c1d\u8bd5\u5398\u6e05\u8fd1\u671f\u4e0a\u5e02\u53d7\u963b\u7684\u836f\u4f01\u51f8\u663e\u7684\u6536\u5165\u6307\u6807\u4e0eIPO\u89c4\u5219\u7684\u5173\u8054\uff0c\u4e43\u81f3\u4e0e\u836f\u4f01\u53cd\u8150\u7684\u7b80\u5355\u903b\u8f91\u7ebf\uff0c\u4f46\u5e76\u975e\u63d0\u51fa\u89e3\u51b3\u95ee\u9898\u7684\u5efa\u8bae\uff0c\u800c\u4ec5\u4e3a\u63d0\u51fa\u4e00\u4e9b\u95ee\u9898\uff0c\u5171\u540c\u601d\u8003\u89e3\u51b3\u95ee\u9898\u7684\u65b9\u6cd5\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u9002\u7528\u7684\u4e0a\u5e02\u89c4\u5219<\/strong><\/span><\/h2>\n<figure id=\"attachment_590934\" aria-describedby=\"caption-attachment-590934\" style=\"width: 200px\" class=\"wp-caption alignright\"><img class=\"wp-image-590934 size-full\" src=\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Zhang-Nan.jpg\" alt=\"Zhang Nan\" width=\"200\" height=\"250\" \/><figcaption id=\"caption-attachment-590934\" class=\"wp-caption-text\"><strong>\u5f20\u6960<\/strong><br \/>\u9ad8\u7ea7\u5408\u4f19\u4eba<br \/>\u6295\u8d44\u4e0e\u57fa\u91d1\u4e1a\u52a1\u90e8\u4e3b\u4efb<br \/>\u709c\u8861\u5f8b\u5e08\u4e8b\u52a1\u6240<br \/>\u7535\u8bdd: +86 138 1778 2085<br \/>\u7535\u5b50\u4fe1\u7bb1: <a href=\"mailto:nan.zhang@weihenglaw.com\">nan.zhang@weihenglaw.com<\/a><\/figcaption><\/figure>\n<p style=\"text-align: justify;\">\u836f\u4f01\u82e5\u7533\u8bf7\u5728\u5883\u5185\u5404\u4ea4\u6613\u6240\u4e0a\u5e02\uff0c\u4e0a\u5e02\u89c4\u5219\u4e2d\u5404\u6863\u6b21\u6807\u51c6\u7684\u8d22\u52a1\u6307\u6807\u7a81\u51fa\u4e86\u8425\u4e1a\u6536\u5165\u89c4\u6a21\u5316\u7684\u5fc5\u8981\u6027\u3002\u5982\u679c\u4ee5\u836f\u4f01\u76f8\u5bf9\u5339\u914d\u7684\u79d1\u521b\u677f\u4e3a\u4f8b\uff0c\u8fd8\u9700\u7b26\u5408\u300a\u79d1\u521b\u5c5e\u6027\u8bc4\u4ef7\u6307\u5f15\uff08\u8bd5\u884c\uff09\u300b\u89c4\u5b9a\u7684\u56db\u9879\u6307\u6807\uff0c\u8be5\u7b49\u6307\u6807\u4e5f\u5f3a\u8c03\u8425\u4e1a\u6536\u5165\u7684\u91cd\u8981\u6027\u3002<\/p>\n<p style=\"text-align: justify;\">\u5c31\u836f\u4f01\u7684\u53d1\u5c55\u8def\u5f84\u800c\u8a00\uff0c\u7531\u4e8e\u836f\u54c1\u5f00\u53d1\u3001\u751f\u4ea7\u5efa\u8bbe\u7b49\u5404\u7c7b\u6210\u672c\u5de8\u5927\uff0c\u82e5\u4ee5\u51c0\u5229\u6da6\u4f5c\u4e3a\u5224\u65ad\u4f01\u4e1a\u88ab\u6295\u8d44\u4ef7\u503c\u6216\u4e0a\u5e02\u7684\u6307\u6807\uff0c\u96be\u4ee5\u8003\u6838\u4e1a\u7ee9\u3002\u56e0\u6b64\uff0c\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u3001\u5e02\u573a\u5360\u6709\u7387\u7b49\u6210\u4e3a\u5176\u53d1\u5c55\u6210\u719f\u5ea6\u7684\u5224\u65ad\u6807\u51c6\u3002\u7531\u6b64\u63a8\u8bba\uff0c\u836f\u4f01\u7684\u6210\u672c\u652f\u51fa\u76f8\u6bd4\u6536\u5165\uff0c\u6536\u5165\u7684\u91cd\u8981\u6027\u8fdc\u5927\u4e8e\u6210\u672c\uff1b\u800c\u6210\u672c\u76f8\u8f83\u800c\u8a00\u53ef\u91c7\u53d6\u6fc0\u8fdb\u7684\u652f\u51fa\u7b56\u7565\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u9500\u552e\u8d39\u7528\u76f8\u5173\u8d22\u52a1\u6307\u6807<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u9274\u4e8e\u836f\u4f01\u6536\u5165\u7684\u91cd\u8981\u6027\u8fdc\u5927\u4e8e\u6210\u672c\uff0c\u82e5\u80fd\u901a\u8fc7\u589e\u52a0\u652f\u51fa\u800c\u63d0\u9ad8\u6536\u5165\u5c06\u662f\u4e0d\u9519\u7684\u9009\u62e9\u3002\u6545\u836f\u4f01\u7684\u9500\u552e\u8d39\u7528\u9ad8\u4f01\u4e0d\u4e0b\uff0c\u5305\u62ec\u63a8\u5e7f\u8d39\u3001\u9500\u552e\u4eba\u5458\u85aa\u916c\u3001\u4e0e\u9500\u552e\u76f8\u5173\u7684\u5dee\u65c5\u8d39\u548c\u529e\u516c\u8d39\u3001\u4e1a\u52a1\u62db\u5f85\u8d39\u3001\u57f9\u8bad\u8d39\u3001\u4f1a\u8bae\u8d39\u7b49\u3002\u7b14\u8005\u4ee5\u4e0a\u5e02\u6216\u62df\u4e0a\u5e02\u836f\u4f01\u9500\u552e\u8d39\u7528\u8d22\u52a1\u6307\u6807\u4e3e\u4f8b\u8bf4\u660e\u5982\u4e0b\uff1a<\/p>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"text-align: justify;\">LJX\u516c\u53f8\u7cfb\u4e00\u5bb6\u4ee5\u5316\u5b66\u836f\u5236\u5242\u53ca\u4e2d\u6210\u836f\u7814\u53d1\u3001\u751f\u4ea7\u4e0e\u9500\u552e\u4e3a\u4e3b\u8425\u4e1a\u52a1\u7684\u521b\u65b0\u578b\u533b\u836f\u5236\u9020\u4f01\u4e1a\u30022019\u5e74\u81f32022\u5e74\u53d1\u884c\u4eba\u9500\u552e\u8d39\u7528\u5360\u8425\u4e1a\u6536\u5165\u7684\u6bd4\u4f8b\u5206\u522b\u4e3a61.29%\u300147.60%\u300146.11%\u300145.09%\uff0c\u5176\u4e2d\u63a8\u5e7f\u670d\u52a1\u8d39\u5360\u9500\u552e\u8d39\u7528\u6bd4\u4f8b\u5206\u522b\u4e3a95.55%\u300193.27%\u300191.22%\u300191.44%\u3002<\/li>\n<li style=\"text-align: justify;\">JTR\u516c\u53f8\u4e3b\u8981\u4ece\u4e8b\u4e2d\u6210\u836f\u7684\u7814\u53d1\u3001\u751f\u4ea7\u548c\u9500\u552e\u30022020\u5e74\u81f32022\u5e74\u53d1\u884c\u4eba\u9500\u552e\u8d39\u7528\u5360\u8425\u4e1a\u6536\u5165\u6bd4\u4f8b\u5206\u522b\u4e3a49.03%\u300150.86%\u300151.95%\uff0c\u5176\u4e2d\u63a8\u5e7f\u8d39\u5360\u9500\u552e\u8d39\u7528\u6bd4\u4f8b\u5206\u522b\u4e3a90.77%\u300194.23%\u300195.29%\u3002<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u4e0a\u5e02\u5ba1\u6838\u53cd\u9988\u95ee\u9898\u53ca\u7b54\u590d<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u4e0a\u5e02\u5ba1\u6838\u53ef\u80fd\u9488\u5bf9\u9ad8\u4f01\u7684\u9500\u552e\u8d39\u7528\u63d0\u95ee\uff0c\u4ee5\u4e0b\u4e3e\u4f8b\u8bf4\u660e\u3002<\/p>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"text-align: justify;\"><strong>\u4e0a\u5e02\u5ba1\u6838\u53cd\u9988\u95ee\u9898\u3002<\/strong>\u8bf7\u53d1\u884c\u4eba\u8bf4\u660e2019\u5e74\u81f32022\u5e74\u95f4\u63a8\u5e7f\u670d\u52a1\u4f1a\u8bae\u53ec\u5f00\u6b21\u6570\u8f83\u591a\u7684\u539f\u56e0\u53ca\u5408\u7406\u6027\uff08\u4f1a\u8bae\u53ec\u5f00\u6b21\u6570\u5206\u522b\u4e3a6013\u6b21\u30018611\u6b21\u30018471\u6b21\u30014024\u6b21\uff09\uff0c\u8bf4\u660e\u63a8\u5e7f\u670d\u52a1\u8d39\u5360\u6bd4\u8f83\u9ad8\u7684\u539f\u56e0\u53ca\u5408\u7406\u6027\uff0c\u662f\u5426\u5b58\u5728\u5546\u4e1a\u8d3f\u8d42\u3001\u865a\u5f00\u53d1\u7968\u3001\u5229\u76ca\u8f93\u9001\u7b49\u60c5\u5f62\u3002<\/li>\n<li style=\"text-align: justify;\"><strong>\u53d1\u884c\u4eba\u7684\u603b\u4f53\u7b54\u590d\u3002<\/strong>\u516c\u53f8\u63a8\u5e7f\u8d39\u76f8\u5bf9\u8f83\u9ad8\uff0c\u4e3b\u8981\u7cfb\uff1a\u533b\u836f\u884c\u4e1a\u4e3a\u54cd\u5e94\u201c\u4e24\u7968\u5236\u201d\u7684\u53f7\u53ec\uff0c\u4ee5\u5904\u65b9\u836f\u4e3a\u4e3b\u7684\u4f01\u4e1a\u5f00\u59cb\u5c06\u4f20\u7edf\u7ecf\u9500\u5546\u6a21\u5f0f\u8f6c\u53d8\u4e3a\u914d\u9001\u5546\u6a21\u5f0f\u3002\u5728\u914d\u9001\u6a21\u5f0f\u4e0b\uff0c\u914d\u9001\u5546\u8d1f\u8d23\u914d\u9001\u836f\u54c1\u5230\u7ec8\u7aef\u533b\u7597\u673a\u6784\uff0c\u800c\u836f\u54c1\u7684\u63a8\u5e7f\u5de5\u4f5c\u5219\u7531\u533b\u836f\u751f\u4ea7\u5546\u8d1f\u8d23\uff0c\u8bb8\u591a\u533b\u836f\u751f\u4ea7\u5546\u7684\u63a8\u5e7f\u80fd\u529b\u6709\u9650\uff0c\u4ece\u800c\u5c06\u63a8\u5e7f\u6d3b\u52a8\u5916\u5305\u7ed9\u7b2c\u4e09\u65b9\u533b\u836f\u63a8\u5e7f\u670d\u52a1\u5546\u3002\u516c\u53f8\u89c4\u6a21\u5c1a\u8f83\u5c0f\uff0c\u9500\u552e\u4eba\u5458\u4e0d\u8db3\u4ee5\u627f\u62c5\u8d77\u5168\u56fd\u5404\u5730\u7684\u63a8\u5e7f\u4efb\u52a1\uff0c\u56e0\u6b64\u5916\u5305\u7ed9\u7b2c\u4e09\u65b9\u533b\u836f\u63a8\u5e7f\u670d\u52a1\u5546\u8fdb\u884c\u3002\u516c\u53f8\u5c1a\u5904\u4e8e\u6210\u957f\u671f\uff0c\u9700\u8981\u8058\u8bf7\u8f83\u591a\u7684\u7b2c\u4e09\u65b9\u533b\u836f\u63a8\u5e7f\u670d\u52a1\u5546\u8fdb\u884c\u76f8\u5e94\u7684\u63a8\u5e7f\u6d3b\u52a8\uff0c\u5bfc\u81f4\u9500\u552e\u8d39\u7528\u7387\u548c\u63a8\u5e7f\u670d\u52a1\u8d39\u7528\u7387\u76f8\u5bf9\u8f83\u9ad8\u3002<\/li>\n<li style=\"text-align: justify;\"><strong>\u53d1\u884c\u4eba\u5bf9\u4f1a\u8bae\u8d39\u652f\u51fa\u7684\u90e8\u5206\u7b54\u590d\u3002<\/strong>\u63a8\u5e7f\u8d39\u652f\u51fa\u4e2d\u79d1\u5ba4\u4f1a\u5360\u6bd4\u76f8\u5bf9\u8f83\u9ad8\uff0c\u4e3b\u8981\u7cfb\uff1a\u4ea7\u54c1\u4e13\u4e1a\u6027\u5f3a\uff0c\u9700\u4e0e\u4e13\u4e1a\u533b\u751f\u76f4\u63a5\u4ea4\u6d41\u4ea7\u54c1\u7597\u6548\uff1b\u516c\u53f8\u63a8\u884c\u7cbe\u51c6\u63a8\u5e7f\uff0c\u79d1\u5ba4\u4f1a\u89c4\u6a21\u76f8\u5bf9\u8f83\u5c0f\uff0c\u91c7\u7528\u79d1\u5ba4\u4f1a\u6a21\u5f0f\u53ef\u76f4\u63a5\u5728\u533b\u9662\u79d1\u5ba4\u4e3e\u884c\uff0c\u66f4\u52a0\u65b9\u4fbf\uff0c\u6548\u7387\u66f4\u9ad8\uff1b\u516c\u53f8\u91cd\u89c6\u4ea7\u54c1\u4e0b\u6c89\uff0c\u4e8c\u7ea7\u533b\u9662\u3001\u53bf\u533a\u7684\u666e\u901a\u533b\u9662\u5f00\u5c55\u5927\u578b\u5b66\u672f\u63a8\u5e7f\u6d3b\u52a8\u96be\u5ea6\u8f83\u5927\uff0c\u79d1\u5ba4\u4f1a\u5f00\u5c55\u66f4\u52a0\u5bb9\u6613\u3002<\/li>\n<li style=\"text-align: justify;\"><strong>\u53d1\u884c\u4eba\u5bf9\u6e20\u9053\u7ef4\u62a4\u8d39\u7684\u90e8\u5206\u7b54\u590d\u3002<\/strong>\u6e20\u9053\u7ef4\u62a4\u4e3b\u8981\u4e3a\u63a8\u5e7f\u670d\u52a1\u5546\u5bf9\u533b\u7597\u7ec8\u7aef\u7684\u7ef4\u62a4\uff0c\u5bf9\u4e8e\u7ec8\u7aef\u533b\u9662\u9700\u8981\u5b9e\u65f6\u5173\u6ce8\u4ea7\u54c1\u914d\u9001\u60c5\u51b5\u3001\u671f\u672b\u5e93\u5b58\u7b49\u5e02\u573a\u6709\u6548\u4fe1\u606f\u641c\u96c6\u53cd\u9988\u3002<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">\u8fd9\u4e9b\u56de\u590d\u96c6\u4e2d\u53cd\u6620\u4e86\u836f\u4f01\u6574\u4f53\u73b0\u72b6\uff0c\u5373\u8425\u9500\u8fdc\u6bd4\u7814\u53d1\u91cd\u8981\uff0c\u4e14\u8d39\u7528\u6bd4\u4f8b\u4e25\u91cd\u5931\u8861\u3002<\/p>\n<h2 style=\"text-align: justify;\"><span class=\"vantage-red\"><strong>\u975e\u6cd5\u652f\u51fa\u7684\u5211\u4e8b\u98ce\u9669<\/strong><\/span><\/h2>\n<p style=\"text-align: justify;\">\u4e3a\u6d88\u5316\u6216\u63a9\u76d6\u5de8\u989d\u9500\u552e\u8d39\u7528\uff0c\u5c24\u5176\u662f\u63a8\u5e7f\u8d39\u7528\uff0c\u5c11\u6570\u836f\u4f01\u7684\u884c\u4e3a\u53ef\u80fd\u4ea7\u751f\u5de8\u5927\u6cd5\u5f8b\u98ce\u9669\uff0c\u5176\u5e2e\u52a9\u8005\u4ea6\u627f\u53d7\u7740\u6cd5\u5f8b\u98ce\u9669\u3002\u4f8b\u5982\uff1a<\/p>\n<ol>\n<li style=\"list-style-type: none;\">\n<ol>\n<li style=\"text-align: justify;\">\u652f\u4ed8\u672a\u771f\u5b9e\u53d1\u751f\u6216\u865a\u589e\u7684\u63a8\u5e7f\u8d39\uff0c\u5f62\u6210\u63a8\u5e7f\u670d\u52a1\u5546\u7684\u4f53\u5916\u79ef\u7d2f\u8d44\u91d1\u7528\u4e8e\u5546\u4e1a\u8d3f\u8d42\uff1b\u5e2e\u52a9\u8005\u5305\u62ec\u63a8\u5e7f\u670d\u52a1\u5546\u53ca\u5176\u5458\u5de5\u3001\u63a8\u5e7f\u670d\u52a1\u5546\u7684\u52b3\u52a1\u5916\u5305\u5355\u4f4d\u3002<\/li>\n<li style=\"text-align: justify;\">\u865a\u589e\u6750\u6599\u7c7b\u91c7\u8d2d\u4ef7\u683c\u6216\u865a\u6784\u91c7\u8d2d\uff0c\u5f62\u6210\u6750\u6599\u7c7b\u4f9b\u5e94\u5546\u7684\u4f53\u5916\u79ef\u7d2f\u8d44\u91d1\u7528\u4e8e\u5546\u4e1a\u8d3f\u8d42\uff1b\u5e2e\u52a9\u8005\u5305\u62ec\u6750\u6599\u7c7b\u4f9b\u5e94\u5546\u3001\u534f\u52a9\u8d44\u91d1\u6d41\u52a8\u8005\u3002<\/li>\n<li style=\"text-align: justify;\">\u9690\u853d\u5173\u8054\u7684\u63a8\u5e7f\u670d\u52a1\u5546\u81ea\u6709\u8d44\u91d1\u7528\u4e8e\u5546\u4e1a\u8d3f\u8d42\uff1b\u5e2e\u52a9\u8005\u5305\u62ec\u80a1\u6743\u4ee3\u6301\u4eba\u3001\u5173\u8054\u63a8\u5e7f\u670d\u52a1\u5546\u7684\u8fd0\u8425\u8005\u3002<\/li>\n<\/ol>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">\u7efc\u4e0a\uff0c\u7b14\u8005\u8ba4\u4e3a\uff0c\u836f\u4f01\u662f\u5426\u80fd\u5c06\u8425\u9500\u4e3a\u738b\u6a21\u5f0f\u8f6c\u6362\u4e3a\u7814\u53d1\u4e3a\u738b\u6a21\u5f0f\uff0c\u4ee5\u53ca\u5982\u4f55\u5408\u6cd5\u63d0\u9ad8\u836f\u4f01\u7684\u4e0b\u6e38\u5ba2\u6237\u5458\u5de5\u5373\u533b\u751f\u7684\u6536\u5165\uff0c\u662f\u836f\u4f01\u5728\u8d44\u672c\u5e02\u573a\u5b9e\u73b0\u79ef\u6781\u6548\u679c\u7684\u9898\u773c\u3002<\/p>\n<hr \/>\n<p style=\"text-align: justify;\"><span class=\"vantage-grey\"><strong><em>\u5f20\u6960\u662f\u709c\u8861\u5f8b\u5e08\u4e8b\u52a1\u6240\u9ad8\u7ea7\u5408\u4f19\u4eba\u3001\u6295\u8d44\u4e0e\u57fa\u91d1\u4e1a\u52a1\u90e8\u4e3b\u4efb\uff0c\u4ed6\u7684\u8054\u7cfb\u65b9\u5f0f\u662f\u7535\u8bdd+86 138 1778 2085\u53ca\u7535\u90aenan.zhang@weihenglaw.com<\/em><\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u672c\u6587\u5c1d\u8bd5\u5398\u6e05\u8fd1\u671f\u4e0a\u5e02\u53d7\u963b\u7684\u836f\u4f01\u51f8\u663e\u7684\u6536\u5165\u6307\u6807\u4e0eIPO\u89c4\u5219\u7684\u5173\u8054\uff0c\u4e43\u81f3\u4e0e\u836f\u4f01\u53cd\u8150\u7684\u7b80\u5355\u903b\u8f91\u7ebf\uff0c\u4f46\u5e76\u975e\u63d0\u51fa\u89e3\u51b3\u95ee\u9898<\/p>\n","protected":false},"author":13501,"featured_media":590928,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"sfsi_plus_gutenberg_text_before_share":"","sfsi_plus_gutenberg_show_text_before_share":"","sfsi_plus_gutenberg_icon_type":"","sfsi_plus_gutenberg_icon_alignemt":"","sfsi_plus_gutenburg_max_per_row":"","meta-author":"\u5f20\u6960\uff0c\u709c\u8861\u5f8b\u5e08\u4e8b\u52a1\u6240"},"categories":[167595,3164,75],"tags":[168054,90722,62295,964,19247,2494,168047,168043,168045,168049,168046,6139,23407,659,168048,168050],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.7 (Yoast SEO v17.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<meta name=\"description\" content=\"\u836f\u4f01IPO\u9047\u963b\uff0c\u9ad8\u9500\u552e\u8d39\u7528\u6210\u5ba1\u6838\u7126\u70b9\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669\" \/>\n<meta property=\"og:description\" content=\"\u836f\u4f01IPO\u9047\u963b\uff0c\u9ad8\u9500\u552e\u8d39\u7528\u6210\u5ba1\u6838\u7126\u70b9\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/\" \/>\n<meta property=\"og:site_name\" content=\"Law.asia\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-09T02:03:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-25T02:54:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:site\" content=\"@ablj_insights\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Website team 05\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#organization\",\"name\":\"Law.asia\",\"url\":\"https:\/\/beta3.law.asia\/zh-hans\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/AsiaBusinessLaw\/\",\"https:\/\/www.linkedin.com\/company\/vantage-asia-publishing-limited\/\",\"https:\/\/twitter.com\/ablj_insights\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#logo\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"contentUrl\":\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png\",\"width\":152,\"height\":152,\"caption\":\"Law.asia\"},\"image\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#website\",\"url\":\"https:\/\/beta3.law.asia\/zh-hans\/\",\"name\":\"Law.asia\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beta3.law.asia\/zh-hans\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg\",\"contentUrl\":\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg\",\"width\":900,\"height\":600,\"caption\":\"Pharma IPO Income Indicators and Risks\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage\",\"url\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/\",\"name\":\"\\u62df\\u4e0a\\u5e02\\u836f\\u4f01\\u7684\\u6536\\u5165\\u6307\\u6807\\u4e0e\\u5ba1\\u6838\\u98ce\\u9669 | Law.asia\",\"isPartOf\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage\"},\"datePublished\":\"2025-06-09T02:03:59+00:00\",\"dateModified\":\"2025-08-25T02:54:55+00:00\",\"description\":\"\\u836f\\u4f01IPO\\u9047\\u963b\\uff0c\\u9ad8\\u9500\\u552e\\u8d39\\u7528\\u6210\\u5ba1\\u6838\\u7126\\u70b9\\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beta3.law.asia\/zh-hans\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\\u62df\\u4e0a\\u5e02\\u836f\\u4f01\\u7684\\u6536\\u5165\\u6307\\u6807\\u4e0e\\u5ba1\\u6838\\u98ce\\u9669\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage\"},\"author\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\"},\"headline\":\"\\u62df\\u4e0a\\u5e02\\u836f\\u4f01\\u7684\\u6536\\u5165\\u6307\\u6807\\u4e0e\\u5ba1\\u6838\\u98ce\\u9669\",\"datePublished\":\"2025-06-09T02:03:59+00:00\",\"dateModified\":\"2025-08-25T02:54:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage\"},\"wordCount\":18,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#organization\"},\"image\":{\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg\",\"keywords\":[\"IPO\\u5ba1\\u6838\",\"\\u4e0a\\u5e02\\u89c4\\u5219\",\"\\u4e2d\\u56fd\\u6d1e\\u5bdf\",\"\\u533b\\u836f\",\"\\u53cd\\u8d3f\\u8d42\",\"\\u5546\\u4e1a\\u8d3f\\u8d42\",\"\\u5ba1\\u6838\\u98ce\\u9669\",\"\\u5f20\\u6960\",\"\\u62df\\u4e0a\\u5e02\\u836f\\u4f01\",\"\\u63a8\\u5e7f\\u8d39\",\"\\u6536\\u5165\\u6307\\u6807\",\"\\u709c\\u8861\\u5f8b\\u5e08\\u4e8b\\u52a1\\u6240\",\"\\u79d1\\u521b\\u677f\",\"\\u8d44\\u672c\\u5e02\\u573a\",\"\\u9500\\u552e\\u8d39\\u7528\",\"\\u975e\\u6cd5\\u652f\\u51fa\"],\"articleSection\":[\"2025\\u5e745\\u6708\\u520a\",\"\\u4e13\\u5bb6\\u7b56\\u7565\",\"\\u5546\\u6cd5\"],\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/beta3.law.asia\/#organization\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b\",\"name\":\"Website team 05\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/beta3.law.asia\/zh-hans\/#personlogo\",\"inLanguage\":\"zh-CN\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5c9209b9cc8cd0af8635efd9c5630d9d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5c9209b9cc8cd0af8635efd9c5630d9d?s=96&d=mm&r=g\",\"caption\":\"Website team 05\"},\"url\":\"https:\/\/beta3.law.asia\/zh-hans\/author\/johnmanson\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"description":"\u836f\u4f01IPO\u9047\u963b\uff0c\u9ad8\u9500\u552e\u8d39\u7528\u6210\u5ba1\u6838\u7126\u70b9\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"zh_CN","og_type":"article","og_title":"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669","og_description":"\u836f\u4f01IPO\u9047\u963b\uff0c\u9ad8\u9500\u552e\u8d39\u7528\u6210\u5ba1\u6838\u7126\u70b9\u3002","og_url":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/","og_site_name":"Law.asia","article_publisher":"https:\/\/www.facebook.com\/AsiaBusinessLaw\/","article_published_time":"2025-06-09T02:03:59+00:00","article_modified_time":"2025-08-25T02:54:55+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@ablj_insights","twitter_site":"@ablj_insights","twitter_misc":{"\u4f5c\u8005":"Website team 05","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/beta3.law.asia\/zh-hans\/#organization","name":"Law.asia","url":"https:\/\/beta3.law.asia\/zh-hans\/","sameAs":["https:\/\/www.facebook.com\/AsiaBusinessLaw\/","https:\/\/www.linkedin.com\/company\/vantage-asia-publishing-limited\/","https:\/\/twitter.com\/ablj_insights"],"logo":{"@type":"ImageObject","@id":"https:\/\/beta3.law.asia\/zh-hans\/#logo","inLanguage":"zh-CN","url":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","contentUrl":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2020\/10\/LAWDOTASIA-LOGO-152.png","width":152,"height":152,"caption":"Law.asia"},"image":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/#logo"}},{"@type":"WebSite","@id":"https:\/\/beta3.law.asia\/zh-hans\/#website","url":"https:\/\/beta3.law.asia\/zh-hans\/","name":"Law.asia","description":"","publisher":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beta3.law.asia\/zh-hans\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"zh-CN"},{"@type":"ImageObject","@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage","inLanguage":"zh-CN","url":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg","contentUrl":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg","width":900,"height":600,"caption":"Pharma IPO Income Indicators and Risks"},{"@type":"WebPage","@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage","url":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/","name":"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669 | Law.asia","isPartOf":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage"},"datePublished":"2025-06-09T02:03:59+00:00","dateModified":"2025-08-25T02:54:55+00:00","description":"\u836f\u4f01IPO\u9047\u963b\uff0c\u9ad8\u9500\u552e\u8d39\u7528\u6210\u5ba1\u6838\u7126\u70b9\u3002","breadcrumb":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beta3.law.asia\/zh-hans\/"},{"@type":"ListItem","position":2,"name":"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669"}]},{"@type":"Article","@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#article","isPartOf":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage"},"author":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b"},"headline":"\u62df\u4e0a\u5e02\u836f\u4f01\u7684\u6536\u5165\u6307\u6807\u4e0e\u5ba1\u6838\u98ce\u9669","datePublished":"2025-06-09T02:03:59+00:00","dateModified":"2025-08-25T02:54:55+00:00","mainEntityOfPage":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#webpage"},"wordCount":18,"commentCount":0,"publisher":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/#organization"},"image":{"@id":"https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#primaryimage"},"thumbnailUrl":"https:\/\/beta3.law.asia\/wp-content\/uploads\/2025\/06\/Income-indicators-and-risks-for-pharma-IPOs.jpg","keywords":["IPO\u5ba1\u6838","\u4e0a\u5e02\u89c4\u5219","\u4e2d\u56fd\u6d1e\u5bdf","\u533b\u836f","\u53cd\u8d3f\u8d42","\u5546\u4e1a\u8d3f\u8d42","\u5ba1\u6838\u98ce\u9669","\u5f20\u6960","\u62df\u4e0a\u5e02\u836f\u4f01","\u63a8\u5e7f\u8d39","\u6536\u5165\u6307\u6807","\u709c\u8861\u5f8b\u5e08\u4e8b\u52a1\u6240","\u79d1\u521b\u677f","\u8d44\u672c\u5e02\u573a","\u9500\u552e\u8d39\u7528","\u975e\u6cd5\u652f\u51fa"],"articleSection":["2025\u5e745\u6708\u520a","\u4e13\u5bb6\u7b56\u7565","\u5546\u6cd5"],"inLanguage":"zh-CN","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/beta3.law.asia\/zh-hans\/pharma-ipo-income-indicators-risks-anti-corruption\/#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/beta3.law.asia\/#organization"}},{"@type":"Person","@id":"https:\/\/beta3.law.asia\/zh-hans\/#\/schema\/person\/1eb0eca4569d71fa927502833bd61d4b","name":"Website team 05","image":{"@type":"ImageObject","@id":"https:\/\/beta3.law.asia\/zh-hans\/#personlogo","inLanguage":"zh-CN","url":"https:\/\/secure.gravatar.com\/avatar\/5c9209b9cc8cd0af8635efd9c5630d9d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5c9209b9cc8cd0af8635efd9c5630d9d?s=96&d=mm&r=g","caption":"Website team 05"},"url":"https:\/\/beta3.law.asia\/zh-hans\/author\/johnmanson\/"}]}},"_links":{"self":[{"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/590938"}],"collection":[{"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/users\/13501"}],"replies":[{"embeddable":true,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/comments?post=590938"}],"version-history":[{"count":2,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/590938\/revisions"}],"predecessor-version":[{"id":591013,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/posts\/590938\/revisions\/591013"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/media\/590928"}],"wp:attachment":[{"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/media?parent=590938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/categories?post=590938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/beta3.law.asia\/zh-hans\/wp-json\/wp\/v2\/tags?post=590938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}